Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 6Plasma cell 5Myeloid 5Other neoplasm 2Classical hematology 2Dermatologic 1

Conditions

Anemia, Refractory, with Excess of Blasts 60Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Myelodysplastic Syndromes 52Leukemia 47Leukemia, Myelomonocytic, Chronic 42Leukemia, Lymphocytic, Chronic, B-Cell 38Multiple Myeloma 36Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 35Myeloproliferative Disorders 34Hodgkin Disease 32Lymphoma 31Congenital Abnormalities 31Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Follicular 28Burkitt Lymphoma 28Primary Myelofibrosis 27Lymphoma, Mantle-Cell 25Anemia, Refractory 25Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 24Blast Crisis 22Anemia, Aplastic 19Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Polycythemia Vera 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 16

Interventions

Cyclophosphamide 4fludarabine phosphate 2fludarabine 2Stem Cell Transplantation 2Platelet Transfusion 2Mycophenolic Acid 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bone Marrow Transplantation 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1cedazuridine 1Thiotepa 1Tacrolimus 1Sertraline 1Rituximab 1Observation 1Methotrexate 1Cyclosporine 1Cholecalciferol 1Brentuximab Vedotin 1Biopsy 1Azacitidine 1Aspirin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × fludarabine phosphate × Classical hematology × Clear all
NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Phase 1/2 Recruiting
12 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡